Latest / The Well-Built Life / Alcohol’s Lethal Path
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:10Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:14Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:23Speaker 1: and let's dive in. Alright Thomas, let's kick this off.
- 0:27Speaker 1: Let's start with what's happening behind the scenes here when
- 0:29Speaker 1: we take that first sip of alcohol. You know, at
- 0:32Speaker 1: the surface, it feels like just a simple liquid passing
- 0:35Speaker 1: through our throat and into our system. But it's actually
- 0:39Speaker 1: quite a complex dance of biochemistry in the background. Right? Exactly.
- 0:43Speaker 2: Because on the surface, it looks straightforward. But when you
- 0:47Speaker 2: dig into the mechanics, the incentives tell a very different story. First,
- 0:52Speaker 2: let's zoom in on the moment of absorption. Right when
- 0:55Speaker 2: that ethanol enters your stomach, it's not being neutralized right away.
- 0:59Speaker 2: It's making its way into the bloodstream, and that's a
- 1:02Speaker 2: critical first step. It's almost like setting the stage for
- 1:05Speaker 2: what's to come. Right.
- 1:08Speaker 1: So, once in the bloodstream, it's a race between elimination
- 1:12Speaker 1: and metabolism. About 10% is excreted unchanged through the kidneys
- 1:17Speaker 1: and lungs. But the bulk of it, about 90%, ends
- 1:20Speaker 1: up in the liver. Here is where the heavy lifting happens.
- 1:25Speaker 1: The primary pathway is via alcohol dehydrogenase, ADH, which uses
- 1:31Speaker 1: NAD as a cofactor to convert ethanol into acetaldehyde. That's
- 1:36Speaker 1: the first hurdle, but it's when heavy or chronic drinking
- 1:39Speaker 1: overloads the system that things get really interesting. It's like
- 1:43Speaker 1: throwing too much weight into a fragile balance. Thomas.
- 1:47Speaker 2: Yes, and when that overload happens, the liver's not just
- 1:51Speaker 2: dealing with the initial hurdle of converting ethanol to acetaldehyde.
- 1:56Speaker 2: It's also got to handle the toxic waste from that process,
- 1:59Speaker 2: namely acetaldehyde, and that's where complications start to arise. Acetaldehyde,
- 2:04Speaker 2: you see, gets stuck to proteins inside the liver cells,
- 2:08Speaker 2: and this is what triggers the immune response and inflammation.
- 2:12Speaker 2: It's almost like the liver is seeing these proteins as
- 2:15Speaker 2: foreign invaders, setting off a whole inflammatory cascade.
- 2:19Speaker 1: That's wild when you look at the raw numbers, Thomas.
- 2:22Speaker 1: The risk factors really highlight how devastating chronic drinking can be.
- 2:26Speaker 1: For women, consuming 14 grams of alcohol a day significantly
- 2:30Speaker 1: raises their risk of liver damage. For men, it's almost
- 2:34Speaker 1: double that at 28 grams. That's not just a small
- 2:37Speaker 1: sip of red wine either. It's a full shot, essentially.
- 2:40Speaker 2: Exactly. which brings up an interesting contradiction. As the liver
- 2:45Speaker 2: processes alcohol, it also needs to handle fats and proteins.
- 2:49Speaker 2: Chronic alcohol use can disrupt these processes. The NADD levels
- 2:54Speaker 2: are dropped, which inhibits beta-oxidation, leading to fat accumulation in
- 2:58Speaker 2: the liver or steatosis. This is the start of the
- 3:01Speaker 2: chain reaction that can lead to cirrhosis. It's like our
- 3:05Speaker 2: liver gets clogged up with fat. And then inflammation follows,
- 3:10Speaker 2: making the situation much worse.
- 3:12Speaker 1: True. And this inflammation, it's like a double-edged sword. It's
- 3:18Speaker 1: necessary to fight off the toxins, but it also causes damage.
- 3:23Speaker 1: Inflammatory neutrophil infiltration leads to satellite necrosis, and the liver
- 3:29Speaker 1: releases pro-inflammatory cytokines. It's a vicious cycle. And Terry's more, Thomas.
- 3:36Speaker 1: The liver cells themselves, the hepatic stellate cells get activated.
- 3:41Speaker 1: They transform into myofibroblasts, producing excessive collagen, leading to fibrosis.
- 3:48Speaker 1: This is the progression from healthy liver to a potentially
- 3:51Speaker 1: life-threatening condition.
- 3:53Speaker 2: Well, it's a journey from innocence to a path of
- 3:55Speaker 2: no return. But the good news is, with this deep understanding,
- 4:00Speaker 2: we are getting closer to more targeted treatments. Ongoing research
- 4:04Speaker 2: is looking at ways to balance inflammation and fibrosis. maybe
- 4:08Speaker 2: even ways to reverse the damages. But in the meantime,
- 4:11Speaker 2: it's crucial for individuals to recognize the signs and make
- 4:15Speaker 2: lifestyle changes, not just to stop drinking but to support
- 4:18Speaker 2: overall liver health.
- 4:19Speaker 1: Absolutely. It's a multifaceted issue, and Therese still so much
- 4:24Speaker 1: we don't know. But the key is awareness and proactive steps.
- 4:29Speaker 1: Whether it's through diet or exercise, there are actionable takeaways
- 4:33Speaker 1: for everyone, not just heavy drinkers. it's a battle worth
- 4:37Speaker 1: fighting for our well-being. So, let's delve into the crux
- 4:41Speaker 1: of how acetaldehyde, mitochondrial dysfunction, and immune responses play their
- 4:45Speaker 1: roles in ALD. As we know, acetaldehyde, the chief culprit,
- 4:51Speaker 1: binds to proteins, essentially setting off an alarm to the
- 4:54Speaker 1: immune system.
- 4:55Speaker 2: Exactly. Think of it as a molecular deception, where acetaldehyde
- 4:59Speaker 2: binds to proteins like a molecular mugger, and the body,
- 5:03Speaker 2: seeing these as foreign invaders, kicks off an inflammatory response.
- 5:07Speaker 2: This isn't just a quick reaction. It can lead to
- 5:10Speaker 2: a prolonged state of inflammation. Right.
- 5:13Speaker 1: And that's the crucial nuance here. This inflammation isn't just
- 5:17Speaker 1: about discomfort. It's a complex cascade that starts with the
- 5:21Speaker 1: recruitment of neutrophils and other immune cells into the liver.
- 5:25Speaker 1: These immune cells release something called damage, associated molecular patterns, damps,
- 5:33Speaker 1: which further amplify the inflammatory signal.
- 5:36Speaker 2: And these damps interact with structures in the cell called inflammasomes,
- 5:40Speaker 2: which then release interleukins, particularly IL-1 beta, enhancing the inflammation
- 5:46Speaker 2: even more. It's like the body's own immune response is
- 5:49Speaker 2: turned into a mechanism for harm. True.
- 5:52Speaker 1: And let's not forget about mitochondrial dysfunction. Acetaldehyde can seriously
- 5:58Speaker 1: disrupt the mitochondria's role in energy production. With NAD levels depleted,
- 6:04Speaker 1: the cell's ability to produce ATP is compromised, and this
- 6:08Speaker 1: leads to a host of problems.
- 6:10Speaker 2: It's a vicious cycle, really. Mitochondrial dysfunction can also generate
- 6:15Speaker 2: ROAS reactive oxygen species, which add to the oxidative stress
- 6:19Speaker 2: in the liver. This further impairs the liver's ability to
- 6:22Speaker 2: detoxify and handle lipids, leading to fat accumulation or steatosis.
- 6:27Speaker 1: And this is where the liver really struggles. With these
- 6:31Speaker 1: fats accumulating, the liver can't function properly, leading to inflammation
- 6:36Speaker 1: and fibrosis. But, wait, but how does this actually play
- 6:40Speaker 1: out in practice? I mean, what's the real-world impact of
- 6:44Speaker 1: this on someone's health?
- 6:45Speaker 2: Well, in the real world, it starts with a buildup
- 6:48Speaker 2: of fat in the liver, often unnoticed, until symptoms like fatigue, swelling,
- 6:54Speaker 2: and even jaundice start appearing. The key is catching these
- 6:57Speaker 2: signs early and making lifestyle changes. including reducing alcohol intake
- 7:01Speaker 2: and adopting a healthy diet and exercise routine.
- 7:04Speaker 1: Exactly, which brings up an interesting contradiction. While these changes
- 7:08Speaker 1: are crucial, they can sometimes be ineffective if not paired
- 7:11Speaker 1: with an understanding of the underlying mechanisms. That's where targeted
- 7:15Speaker 1: interventions for acetaldehyde management and mitochondrial health could play a
- 7:19Speaker 1: vital role.
- 7:20Speaker 2: Absolutely. Research is hinting at ways to balance inflammation and fibrosis,
- 7:25Speaker 2: maybe even reverse some damage. But for now, It's about
- 7:29Speaker 2: educating ourselves and adopting a holistic approach to liver health,
- 7:33Speaker 2: not just cutting out alcohol, but also focusing on other
- 7:37Speaker 2: health factors that might play a role.
- 7:39Speaker 1: So, let's dive into how the interactions between patients, clinicians,
- 7:43Speaker 1: and liver cells can be so complex and dynamic. For instance,
- 7:48Speaker 1: what we see in practice often doesn't fully align with
- 7:51Speaker 1: the theoretical models we have for liver pathology.
- 7:54Speaker 2: Exactly. Take, for example … the balance between liver cell
- 7:58Speaker 2: health and the immune response. Clinicians often treat old patients
- 8:02Speaker 2: with anti-inflammatory medications, but for some, this might actually exacerbate
- 8:07Speaker 2: the condition by stopping the necessary inflammatory response that could
- 8:11Speaker 2: clear out damaged cells.
- 8:12Speaker 1: Right, and that's the crucial nuance here. It's not just
- 8:16Speaker 1: about calming down the inflammation. We need to understand when
- 8:20Speaker 1: and how to intervene. How do these interactions look on
- 8:24Speaker 1: a micro level, Thomas?
- 8:25Speaker 2: Well, let's use the analogy of a soccer field. The
- 8:28Speaker 2: liver cells are the players, the immune cells are the referees,
- 8:32Speaker 2: and the gut bacteria are the fans. Sometimes, you need
- 8:36Speaker 2: the fans to cheer the players, but other times, you
- 8:39Speaker 2: need them to be silent so the referees can see
- 8:41Speaker 2: the game clearly. It's all about finding the balance.
- 8:44Speaker 1: That's a great analogy. And when you look at it,
- 8:47Speaker 1: it's fascinating how the gut microbiota can play such a
- 8:50Speaker 1: pivotal role. Not only do they produce endotoxins that can
- 8:54Speaker 1: damage liver cells, but they can also produce protective molecules
- 8:58Speaker 1: that reduce inflammation. It's like having two sides of the
- 9:01Speaker 1: same coin.
- 9:02Speaker 2: Absolutely. This dual-edged roll of gut bacteria highlights the importance
- 9:07Speaker 2: of a holistic approach. Clinicians often focus on the liver itself,
- 9:12Speaker 2: but they often ignore the broader influences from the gut.
- 9:16Speaker 2: In fact, some studies show that probiotics can help reduce
- 9:19Speaker 2: liver damage by modulating the gut-liver axis.
- 9:22Speaker 1: That's wild when you look at the raw numbers. One
- 9:25Speaker 1: study found that certain strains of probiotics decreased serum levels
- 9:29Speaker 1: of pro-inflammatory cytokines in ailed patients. It's interesting how simple
- 9:35Speaker 1: interventions can have such profound effects.
- 9:37Speaker 2: Exactly. And it's not just about the probiotics. The clinician-patient
- 9:42Speaker 2: interaction is equally crucial. Patients who feel supported and informed
- 9:47Speaker 2: are much more likely to adhere to treatment plans. Clinicians
- 9:50Speaker 2: need to provide not just medical advice, but also psychological support,
- 9:55Speaker 2: which can significantly impact compliance and outcomes.
- 9:58Speaker 1: That's a huge shift. It's not just about prescribing medication.
- 10:02Speaker 1: It's about building a relationship where the patient feels heard
- 10:05Speaker 1: and understood. And this is just the tip of the iceberg.
- 10:09Speaker 1: To re-still so much we don't know, like the specific
- 10:11Speaker 1: mechanisms by which certain enzymes or pathways can be targeted
- 10:16Speaker 1: to improve liver health.
- 10:17Speaker 2: Absolutely. Ongoing research is desperately needed to unravel these mechanisms.
- 10:22Speaker 2: For instance, understanding how the liver cells communicate with the
- 10:26Speaker 2: immune system or how the NAD depletion affects beta-oxidation could
- 10:30Speaker 2: lead to targeted therapies that actually support rather than hinder
- 10:33Speaker 2: the natural healing processes.
- 10:35Speaker 1: Right, and that's the crucial nuance here. When we talk
- 10:39Speaker 1: about beta-oxidation, the contradiction really starts to emerge as we
- 10:43Speaker 1: look at how NAD levels drop. And this isn't just
- 10:47Speaker 1: a one-way street.
- 10:48Speaker 2: Exactly. Because let's dive into the specifics. Beta oxidation is
- 10:52Speaker 2: typically a process that breaks down fats to produce energy.
- 10:56Speaker 2: But with chronic alcohol consumption, beta oxidation gets thrown into
- 11:01Speaker 2: a bit of a paradox.
- 11:02Speaker 1: Exactly. It's like the body is stuck in a loop
- 11:05Speaker 1: where it's trying to clear fat but can't because the
- 11:08Speaker 1: NAD levels are too low. That's where the contradiction kicks in.
- 11:12Speaker 2: Right. And this isn't just a theoretical issue. It has
- 11:15Speaker 2: real-world implications. For example, dietary interventions that aim to improve
- 11:21Speaker 2: fat metabolism aren't as effective in recovering these NID levels.
- 11:25Speaker 2: It's a catch-negative-22 situation.
- 11:28Speaker 1: That's absolutely wild when you look at the raw numbers.
- 11:31Speaker 1: Studies show that even when someone reduces their alcohol intake,
- 11:34Speaker 1: the recovery of beta-oxidation can be slow. If it happens
- 11:37Speaker 1: at all.
- 11:38Speaker 2: And it's not just about the beta-xanoxidation. You have got
- 11:42Speaker 2: to remember that CipRO is another actor in this drama.
- 11:46Speaker 2: This enzyme, while important for acetaldehyde detoxification, can actually cause
- 11:52Speaker 2: more harm than good when alcohol is involved.
- 11:55Speaker 1: Exactly. CipRO is a double-zanned-edged sword. It's supposed to help
- 12:00Speaker 1: clear the acetaldehyde, but when overproduced due to chronic alcohol use,
- 12:05Speaker 1: It produces even more rose and oxidative stress.
- 12:08Speaker 2: That's the paradox. It's almost as if the body is
- 12:11Speaker 2: fighting a fire with gasoline. On one hand, reducing alcohol
- 12:15Speaker 2: intake seems like it should be good. Yet these enzymes
- 12:18Speaker 2: are working against us.
- 12:20Speaker 1: And it's not just a simple case of increased risk.
- 12:23Speaker 1: Look at the historical parallels. Centuries of heavy drinking and
- 12:28Speaker 1: the evolution of these metabolic pathways. How did we get
- 12:31Speaker 1: to a point where these systems... seem to be in
- 12:34Speaker 1: conflict with the very thing they need to survive.
- 12:36Speaker 2: It's fascinating. The microbiome debate is another layer. How does
- 12:41Speaker 2: the shift in gut bacteria affect everything? Research is showing
- 12:46Speaker 2: that the microbiome can either exacerbate or mitigate liver damage.
- 12:50Speaker 1: And it's also connected. Take, for example, the role of endotoxins.
- 12:55Speaker 1: These can increase gut permeability, leading to increased inflammation. And
- 13:00Speaker 1: that inflammation... just feeds the oxidative stress loop.
- 13:03Speaker 2: It's like the body is stuck in a vicious cycle.
- 13:06Speaker 2: The liver is fighting fires internally, and the gut is
- 13:09Speaker 2: adding to the burden, creating an environment prone to further damage.
- 13:13Speaker 1: And the good news is that understanding these contradictions is
- 13:17Speaker 1: leading to new avenues of research. Personalized medicine may hold
- 13:22Speaker 1: the key to managing ALD by tailoring treatments to the
- 13:25Speaker 1: specific needs of the liver and the microbiome.
- 13:28Speaker 2: Exactly. And with advancements in gene editing and molecular therapies,
- 13:33Speaker 2: we might see breakthroughs in reversing fibrosis and other aspects
- 13:37Speaker 2: of liver damage. It's definitely a space to keep an
- 13:40Speaker 2: eye on.
- 13:40Speaker 1: So, let's dive into some of the exciting future prospects.
- 13:45Speaker 1: Biomarkers are really starting to shine in the field of ALLD,
- 13:49Speaker 1: allowing for earlier and more accurate diagnoses. Thomas, what do
- 13:54Speaker 1: you think the future holds for biomarkers in managing this condition?
- 13:58Speaker 2: Well, Rachel … It's about precision. Biomarkers like serum alanine transaminase,
- 14:04Speaker 2: alt and aspartate transaminase-acid have been used for a while,
- 14:08Speaker 2: but the landscape is expanding. For instance, to raise research
- 14:12Speaker 2: into specific inflammatory markers and micronas that could predict liver
- 14:16Speaker 2: fibrosis early on. This would be transformative, as it could
- 14:20Speaker 2: lead to more personalized treatment plans.
- 14:23Speaker 1: Absolutely. The ability to tailor treatments based on biomarker profiles
- 14:28Speaker 1: sounds game-changing. Now, speaking of personalization, gene editing technologies like
- 14:34Speaker 1: CRISPR are getting a lot of attention. Can you explain
- 14:38Speaker 1: how these new techniques might specifically impact ALD?
- 14:42Speaker 2: Sure. Gene editing offers a direct approach to tweaking the
- 14:45Speaker 2: fundamental machinery involved. For example … CRISPR could theoretically correct
- 14:51Speaker 2: genetic mutations that predispose individuals to liver disease. More practically,
- 14:56Speaker 2: it's exciting for treating conditions like viral hepatitis, which can
- 14:59Speaker 2: lead to ALT. By editing the liver at a genetic level,
- 15:03Speaker 2: we might restore normal function or even prevent damage entirely.
- 15:07Speaker 1: That's fascinating. And just like the gut microbiome plays a
- 15:11Speaker 1: crucial role in overall health, its influence on the liver
- 15:15Speaker 1: shouldn't be overlooked. How do gut-liver interactions factor into these advancements?
- 15:20Speaker 2: Great question. Research is uncovering strong links between the gut
- 15:25Speaker 2: microbiome and liver health. For instance, certain bacteria can produce
- 15:30Speaker 2: toxins that enter the liver, exacerbating inflammation. In the future,
- 15:35Speaker 2: we might see probiotics or synthetic biology approaches to modulate
- 15:40Speaker 2: the microbiome, thereby reducing liver damage. It's a synergistic approach
- 15:45Speaker 2: that could significantly improve outcomes.
- 15:48Speaker 1: So, it seems like we are at a pivot point
- 15:51Speaker 1: where multiple disciplines are converging. What practical steps can people
- 15:55Speaker 1: take now to support their liver health, given these developments?
- 15:59Speaker 2: Well, maintaining a balanced diet, regular exercise, and limiting alcohol
- 16:04Speaker 2: are foundational. But as we move forward, people might consider
- 16:07Speaker 2: taking a more proactive role. For example, using diet and
- 16:11Speaker 2: supplements that support gut health. or even engaging in gene
- 16:14Speaker 2: testing to monitor their risk factors.
- 16:16Speaker 1: Exactly. It's about staying informed and prepared. Thank you, Thomas,
- 16:21Speaker 1: for shedding light on these exciting developments.
- 16:23Speaker 2: My pleasure, Rachel. It's an exciting time to be involved
- 16:26Speaker 2: in this field.
- 16:27Speaker 1: That brings us to the end of today's episode. Thank
- 16:30Speaker 1: you so much for spending part of your day with me.
- 16:33Speaker 1: If you found this episode's tips helpful and want to
- 16:35Speaker 1: make sure you don't miss the next conversation, please take
- 16:39Speaker 1: a quick second to hit that subscribe button. or follow
- 16:41Speaker 1: button on whatever platform you are listening on. It's a
- 16:45Speaker 1: completely free way to support the show and helps more
- 16:47Speaker 1: people find us. This podcast is independently produced, so if
- 16:52Speaker 1: you are ever in a position where you would like
- 16:54Speaker 1: to help keep it running, we do accept small donations.
- 16:57Speaker 1: You can find a link right in the episode description
- 17:00Speaker 1: below to buy us a coffee or contribute what you can.
- 17:04Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 17:08Speaker 1: and we will talk again soon.